Boston Scientific Launches Four Innovative Medical Devices in China at CIIE to Support Healthy Aging

Shanghai, November 7, 2020 /PRNewswire/ -- At the third China International Import Expo, Boston Scientific (NYSE: BSC), a global leader in innovative medical technology, announced the official launch of four innovative products in China. These products will provide novel solutions for cardiovascular, peripheral vascular, and pancreaticobiliary cancer indications, thereby bringing cutting-edge global medical technologies to benefit a broad population of patients in China and supporting healthy aging through innovation.

Boston Scientific New Product Launch Ceremony

Boston Scientific has launched four products, including: the world’s first polymer-coated peripheral artery drug-eluting stent—Eluvia™ paclitaxel-eluting nitinol vascular stent; OptiCross™ HD, the world’s first 60 MHz single-use intravascular ultrasound diagnostic catheter featuring clearer intravascular ultrasound imaging and superior penetration capability; and WOLVERINE, the only cutting balloon catheter available in China that provides efficient vascular pre-dilation solutions.^®and the Habib EndoHPB radiofrequency ablation catheter, an interventional surgical device for cholangiocarcinoma that received the Gold Award in the "Advanced Surgical Devices" category at the 2020 Edison Awards.

“Boston Scientific is dedicated to minimally invasive interventional therapies, leveraging its global innovation capabilities and continuous medical advancements to deliver increasingly precise and appropriate treatment solutions, thereby alleviating the disease diagnosis and treatment burden exacerbated by population aging,” said Ms. Zhang Jun, President of Boston Scientific’s Greater China region. “We are honored to advance alongside the China International Import Expo (CIIE). By harnessing this open platform for cooperation, we aim to root ourselves in China, bring cutting-edge global innovations to benefit local patients, and contribute to the building of a Healthy China.”

For contraindications and precautions, see the package insert.
Registrant/Manufacturer Name：Boston Scientific Corporation
Registration Certificate No.: Guo Xie Zhu Jin 20203130358 Product Name: Eluvia OVER-THE-WIRE Drug-Eluting Vascular Stent System Nitinol Paclitaxel-Eluting Vascular Stent
Registration Certificate No.: National Medical Device Import Registration 20203060148 Product Name: OptiCross™ HD 60MHz Coronary Imaging Catheter Disposable Intravascular Ultrasound Diagnostic Catheter
Registration Certificate No.: Guo Xie Zhu Jin 20173775044 Product Name: Habib EndoHPB Radiofrequency Ablation Catheter
Registration Certificate No.: Guo Xie Zhu Jin 20203030164 Product Name: Wolverine^TMCoronary Cutting Balloon Monorail Microsurgical Dilatation Device
PSST-CN-202011-0018/ Version A/ Expected Effective Date: November 7, 2020
Internal & External © 2020 by Boston Scientific Corporation or its affiliates. All rights reserved

About Boston Scientific

Boston Scientific Corporation is committed to innovating for life. We are dedicated to developing innovative medical solutions that improve the lives of patients worldwide. For more than four decades, Boston Scientific has been a leader in the global medical technology industry, offering a broad portfolio of high-performance medical solutions to meet the urgent therapeutic needs of a wide patient population and reduce healthcare costs. For more information, please visit our corporate website:www.bostonscientific.cn

About Boston Scientific Greater China

Boston Scientific established its China headquarters in Shanghai in 1997 and currently maintains branch offices in Beijing, Shanghai, Guangzhou, Chengdu, Hong Kong, and Taiwan. The company’s core business areas include interventional cardiology, structural heart disease, cardiac rhythm management and electrophysiology, endoscopic interventions, peripheral and oncology interventions, urology and pelvic health, and respiratory products. Upholding its tradition as an innovation leader, Boston Scientific is committed to becoming a respected medical technology company that is responsive to the needs of patients and healthcare providers, driven by innovative vitality, through the provision of high-quality medical products and services for prevention, diagnosis, and treatment. For more detailed information, please visit the company’s website:www.bostonscientific.cn